Ferrer Internacional, S.A.
Records under this name other than the patents Ferrer Internacional, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Ferrer Internacional, S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,545,816 | Benzoic acid ester compounds, compositions, uses and methods related thereto Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,753,680 | Capsule for the prevention of cardiovascular diseases Lapsed on the fee record Ended Jun 17, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 17, 2026 | From the USPTO record |
| US 8,507,684 | 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts Lapsed on the fee record Ended Aug 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2025 | From the USPTO record |
| US 7,635,691 | Use of CDP-choline for the prophylactic treatment of cerebral ischemia Term ended Term ended Nov 9, 2023 · From the USPTO record | Term ended | Term ended Nov 9, 2023 | From the USPTO record |
| US 8,039,476 | Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide Lapsed on the fee record Ended Oct 18, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 18, 2023 | From the USPTO record |
| US 8,008,486 | Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound Lapsed on the fee record Ended Aug 30, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2023 | From the USPTO record |
| US 10,072,000 | Method of treating insomnia with halogenated pyrazolo[1,5-a]pyrimidines Lapsed on the fee record Ended Sep 11, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 11, 2022 | From the USPTO record |
| US 8,530,482 | Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates Lapsed on the fee record Ended Sep 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 10, 2021 | From the USPTO record |
| US 6,894,032 | Use of CDP-choline for the treatment of alcohol withdrawal syndrome Formerly held Term ended Term ended Jul 28, 2021 · From the USPTO record | Term ended | Term ended Jul 28, 2021 | From the USPTO record |
| US 6,930,096 | Use of CDP-choline for the prophylactic treatment of cerebral ischemia Formerly held Term ended Term ended Apr 22, 2021 · From the USPTO record | Term ended | Term ended Apr 22, 2021 | From the USPTO record |